TTI-0102
Nephropathic Cystinosis
Phase 3 (planned)Active
Key Facts
Indication
Nephropathic Cystinosis
Phase
Phase 3 (planned)
Status
Active
About Thiogenesis Therapeutics
A private biotech leveraging engineered thiol prodrugs to treat mitochondrial and metabolic diseases with improved safety and efficacy.
View full company profileAbout Thiogenesis Therapeutics
A private biotech leveraging engineered thiol prodrugs to treat mitochondrial and metabolic diseases with improved safety and efficacy.
View full company profileAbout Thiogenesis Therapeutics
A private biotech leveraging engineered thiol prodrugs to treat mitochondrial and metabolic diseases with improved safety and efficacy.
View full company profileAbout Thiogenesis Therapeutics
A private biotech leveraging engineered thiol prodrugs to treat mitochondrial and metabolic diseases with improved safety and efficacy.
View full company profileAbout Thiogenesis Therapeutics
A private biotech leveraging engineered thiol prodrugs to treat mitochondrial and metabolic diseases with improved safety and efficacy.
View full company profile